276 related articles for article (PubMed ID: 31732848)
1. Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU.
Ali F; Wijdicks EF
Neurocrit Care; 2020 Feb; 32(1):286-294. PubMed ID: 31732848
[TBL] [Abstract][Full Text] [Related]
2. Movement disorders in paraneoplastic and autoimmune disease.
Panzer J; Dalmau J
Curr Opin Neurol; 2011 Aug; 24(4):346-53. PubMed ID: 21577108
[TBL] [Abstract][Full Text] [Related]
3. Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.
Wong-Kisiel LC; Ji T; Renaud DL; Kotagal S; Patterson MC; Dalmau J; Mack KJ
Neurology; 2010 May; 74(19):1550-1. PubMed ID: 20458074
[No Abstract] [Full Text] [Related]
4. Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults.
Vincent A; Bien CG
Lancet Neurol; 2008 Dec; 7(12):1074-5. PubMed ID: 18851929
[No Abstract] [Full Text] [Related]
5. [Anti-NMDA receptor encephalitis: two paediatric cases].
González-Toro MC; Jadraque-Rodríguez R; Sempere-Pérez Á; Martínez-Pastor P; Jover-Cerdá J; Gómez-Gosálvez F
Rev Neurol; 2013 Dec; 57(11):504-8. PubMed ID: 24265144
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune and paraneoplastic movement disorders: An update.
Baizabal-Carvallo JF; Jankovic J
J Neurol Sci; 2018 Feb; 385():175-184. PubMed ID: 29406902
[TBL] [Abstract][Full Text] [Related]
7. Current therapies for neuromuscular manifestations of paraneoplastic syndromes.
Rosenfeld MR; Dalmau J
Curr Neurol Neurosci Rep; 2006 Jan; 6(1):77-84. PubMed ID: 16469274
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune encephalitis, clinical, radiological and immunological data].
Aupy J; Collongues N; Blanc F; Tranchant C; Hirsch E; De Seze J
Rev Neurol (Paris); 2013 Feb; 169(2):142-53. PubMed ID: 23099105
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.
Iorio R; Damato V; Evoli A; Gessi M; Gaudino S; Di Lazzaro V; Spagni G; Sluijs JA; Hol EM
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):138-146. PubMed ID: 28951498
[TBL] [Abstract][Full Text] [Related]
10. Immune-mediated epilepsy with GAD65 antibodies.
Li X; Guo Q; Zheng Z; Wang X; Liu S
J Neuroimmunol; 2020 Apr; 341():577189. PubMed ID: 32087461
[TBL] [Abstract][Full Text] [Related]
11. Movement disorders in autoimmune diseases.
Baizabal-Carvallo JF; Jankovic J
Mov Disord; 2012 Jul; 27(8):935-46. PubMed ID: 22555904
[TBL] [Abstract][Full Text] [Related]
12. Movement disorders ii: chorea, dystonia, myoclonus, and tremor.
Mink JW; Zinner SH
Pediatr Rev; 2010 Jul; 31(7):287-94; quiz 295. PubMed ID: 20595442
[No Abstract] [Full Text] [Related]
13. Movement Disorders in Chronic Kidney Disease - A Descriptive Review.
Safarpour Y; Vaziri ND; Jabbari B
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105408. PubMed ID: 33139171
[TBL] [Abstract][Full Text] [Related]
14. Parkinsonism in autoimmune diseases.
Barba C; Alexopoulos H
Int Rev Neurobiol; 2019; 149():419-452. PubMed ID: 31779823
[TBL] [Abstract][Full Text] [Related]
15. Movement disorders in autoimmune encephalitis and paraneoplastic neurological syndromes.
Honnorat J; Joubert B
Rev Neurol (Paris); 2018 Nov; 174(9):597-607. PubMed ID: 30201423
[TBL] [Abstract][Full Text] [Related]
16. Neurological autoimmune disorders with prominent gastrointestinal manifestations: A review of presentation, evaluation, and treatment.
Blackburn KM; Kubiliun M; Harris S; Vernino S
Neurogastroenterol Motil; 2019 Oct; 31(10):e13611. PubMed ID: 31016817
[TBL] [Abstract][Full Text] [Related]
17. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
[TBL] [Abstract][Full Text] [Related]
18. Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease.
Tan TH; Perucca P; O'Brien TJ; Kwan P; Monif M
Epilepsia; 2021 Feb; 62(2):303-324. PubMed ID: 33316111
[TBL] [Abstract][Full Text] [Related]
19. Current therapies and therapeutic decision making for childhood-onset movement disorders.
Mohammad SS; Paget SP; Dale RC
Mov Disord; 2019 May; 34(5):637-656. PubMed ID: 30919519
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic movement disorders.
Mehta SH; Morgan JC; Sethi KD
Curr Neurol Neurosci Rep; 2009 Jul; 9(4):285-91. PubMed ID: 19515280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
